MedTrace Logo

IV Glucose for Dehydration Treatment

NCT01285713 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2019-03-19

Study results available
· View outcomes & findings →

Summary

To determine whether the addition of dextrose to IV fluids in the treatment of gastroenteritis leads to a decrease in serum ketones. Secondarily, the clinical benefits of dextrose containing fluids in the treatment of gastroenteritis will be assessed.

Conditions

Interventions

DRUG

5% Dextrose (D5) in Normal Saline (NS)

D5NS 10 cubic centimeter (cc)/kilogram (kg) to be followed by 30cc/kg of NS

DRUG

Normal Saline (NS)

NS 10 cubic centimeter (cc)/kilogram (kg) to be followed by 30cc/kg NS

Sponsors & Collaborators

Principal Investigators

  • Elizabeth R Alpern, MD · Children's Hospital of Philadelphia

  • Kari Posner, MD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-08-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01285713 on ClinicalTrials.gov